Skip to main content
OpenTrials

Clinical trial condition

Waldenstrom Macroglobulinemia

Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.

107 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Waldenstrom Macroglobulinemia trial results

Active, Not Recruiting

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

NCT04624906

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

NCT05952037

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

NCT03620903

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Studiengesellschaft Onkologie Bielefeld GbR Bielefeld, Germany
  • DIAKO Ev. Diakonie-Krankenhaus gGmbH, Med. Klinik II Bremen, Germany
  • Universitätsklinikum Halle, Klinik für Innere Medizin IV Halle, Germany
  • Universtätsmedizin Mannheim, III. Medizinische Klinik Studienzentrale im MCC Mannheim, Germany
View Trial Details
Active, Not Recruiting

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

NCT04464200

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details

Related conditions